Business EconomyPosted at: Nov 15 2025 1:11AM


Capillary Technologies IPO opens at ₹549–₹577

Bengaluru, Nov 14 (UNI) Capillary Technologies India Limited opened its Initial Public Offer (IPO) on Friday, fixing a price band of ₹549 to ₹577 per equity share of face value ₹2.
The issue will remain open for subscription till November 18, with investors allowed to bid for a minimum of 25 equity shares and in multiples of 25 thereafter.
The public issue comprises a fresh issue of equity shares aggregating to ₹3,450 million and an offer-for-sale of 92,28,796 equity shares.
According to the company, net proceeds from the fresh issue will be utilised as follows: up to ₹1,430 million for cloud infrastructure costs, up to ₹715.81 million for research, design and product development, up to ₹103.42 million for purchase of computer systems, and the remaining for inorganic growth through unidentified acquisitions and general corporate purposes.
The company clarified that expenditure towards general corporate purposes and unidentified acquisitions together will not exceed 35 per cent of gross proceeds, with each capped at 25 per cent. Further, utilisation towards capital expenditure will not exceed 50 per cent of fresh issue proceeds.
Capillary Technologies is a software product firm offering AI-driven, cloud-native Software-as-a-Service solutions targeted at enterprise customers seeking to build consumer and channel loyalty. Benchmarking by Zinnov as of September 2025 positions the firm among the global leaders in loyalty and engagement management.
The company provides end-to-end loyalty management through its product suite comprising Loyalty , Engage , Insights , Rewards and its customer data platform. As of September 30, 2025, it supports over 410 brands across 47 countries.
For the six months ended September 30, 2025, the company recorded consolidated revenue from operations of ₹3,592.18 million, compared with ₹2,871.77 million in the same period last year. Revenue stood at ₹5,982.59 million in FY25, ₹5,251 million in FY24 and ₹2,553.72 million in FY23.
JM Financial Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited are the book-running lead managers, while MUFG Intime India Private Limited is the registrar.
The offer is being made through the book-building route. Not more than 75 per cent of the net offer will be reserved for qualified institutional buyers, not more than 15 per cent for non-institutional bidders and not more than 10 per cent for retail individual bidders, subject to valid bids at or above the offer price. UNI BDN SSP
Please log in to get detailed story.
Tags: #Capillary Technologies IPO opens at ₹549–₹577
More News

RBI’s rate cut sets pro-growth tone as Inflation outlook softens sharply: SBI

06 Dec 2025 | 8:23 PM

New Delhi, Dec 6 (UNI) The Reserve Bank of India’s latest move to cut the repo rate by 25 basis points to 5.25 per cent reflects a clear commitment to support growth at a time when inflation is easing sharply and global uncertainties are rising, SBI said in its Ecowrap report.

see more..

India should launch National Satellite Connectivity Mission: SIA-India

06 Dec 2025 | 3:47 PM

Chennai, Dec 6 (UNI) Space Industry Association of India (SIA-India) SIA-India has called for the launch of a National Satellite Connectivity Mission (NSCM) to ensure uninterrupted digital governance and public service continuity in about 40,000 Gram Panchayats where terrestrial links repeatedly fail due to topographical challenges, multi-week outage cycles, and chronic disaster exposure. .

see more..

PHDCCI proposes direct tax reforms to drive investment and ease of doing business

06 Dec 2025 | 2:45 PM

New Delhi, Dec 6 (UNI) The PHD Chamber of Commerce and Industry (PHDCCI) has put forward an extensive set of recommendations to the government, calling for a major overhaul of India’s direct tax framework.

see more..

Netflix announces deal to buy Warner Bros & HBO

06 Dec 2025 | 3:45 AM

California, Dec 5 (UNI) In a major development in media industry, Netflix has triumphed in the bidding war for Warner Bros. and HBO, announcing a deal that could combine two of the three biggest streamers with one of the largest traditional movie and television studios.

see more..

Lupin gets US FDA approval for multiple sclerosis tablet

05 Dec 2025 | 8:43 PM

Chennai, Dec 5 (UNI) Pharmaceutical major Lupin Ltd on Friday announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Siponimod Tablets, 0.25 mg, 1 mg, and 2 mg.
This product would be manufactured at Lupin’s Pithampur facility in India.

see more..